K
Kim A. Eagle
Researcher at University of Michigan
Publications - 852
Citations - 85694
Kim A. Eagle is an academic researcher from University of Michigan. The author has contributed to research in topics: Aortic dissection & Myocardial infarction. The author has an hindex of 129, co-authored 823 publications receiving 75160 citations. Previous affiliations of Kim A. Eagle include University of Wisconsin Hospital and Clinics & Spaulding Rehabilitation Hospital.
Papers
More filters
Journal Article
The impact of diagnostic tests in evaluating patients with syncope.
Kim A. Eagle,Henry R. Black +1 more
TL;DR: The data suggest that extensive neurologic testing in patients with "routine" syncope is not warranted and that the focus of hospitalization should be to rule out potentially life-threatening arrhythmias.
Journal ArticleDOI
Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery.
TL;DR: It is concluded that preoperative planar DTS is most useful to stratify selected nonvascular surgery patients at intermediate or high risk by clinical assessment, however, for almost half of those patients with known or suspected coronary artery disease, DTS may be unnecessary because of sufficiently low predictive value based on simple clinical descriptors.
Journal ArticleDOI
Aortic Complications Associated With Pregnancy in Marfan Syndrome: The NHLBI National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)
Mary J. Roman,Norma Pugh,Tabitha Hendershot,Richard B. Devereux,Hal Dietz,Kathryn W. Holmes,Kim A. Eagle,Scott A. LeMaire,Dianna M. Milewicz,Shaine A. Morris,Reed E. Pyeritz,William Ravekes,Ralph V. Shohet,Michael Silberbach +13 more
TL;DR: Pregnancy in MFS is associated with an increased risk of aortic dissection, both types A and B, particularly in the immediate postpartum period, and the need for early diagnosis, prepregnancy risk counseling, and multidisciplinary peripartum management is underscored.
Journal ArticleDOI
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon,Deepak L. Bhatt,Yedid Elbez,Victor Aboyans,Sonia S. Anand,Jackie Bosch,Kelley R. Branch,Stuart J. Connolly,Leanne Dyal,John W. Eikelboom,Keith A.A. Fox,Katalin Keltai,Jeffrey L. Probstfield,Salim Yusuf,Jérémie Abtan,Emmanuel Sorbets,Kim A. Eagle,Gregory Ducrocq,Gregory Ducrocq,Philippe Gabriel Steg +19 more
TL;DR: The proportion of patients eligible for the COMPASS trial within the Reduction of Atherothrombosis for Continued Health (REACH) registry is described, suggesting good external applicability, and COMPASS-Eligible patients experienced a higher rate of the primary outcome compared with COMPASS participants in the aspirin alone treatment arm.
Journal ArticleDOI
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
Sami Alnasser,Sami Alnasser,Wei Huang,Joel M. Gore,Phillippe Gabriel Steg,Kim A. Eagle,Frederick A. Anderson,Keith A.A. Fox,Enrique P. Gurfinkel,David Brieger,Werner Klein,Frans Van de Werf,Alvaro Avezum,Gilles Montalescot,Dietrich C. Gulba,Andrzej Budaj,Jose Lopez-Sendon,Christopher B. Granger,Brian M. Kennelly,Robert J. Goldberg,Emily Fleming,Shaun G. Goodman +21 more
TL;DR: The discriminative accuracy of the GRACE risk score in hospital survivors for predicting longer-term mortality was maintained, and there were important later adverse consequences, including frequent morbidity and mortality in this large multinational cohort of acute coronary syndrome patients.